Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer

Cabazitaxel provided a survival advantage compared with mitoxantrone in patients with castration-resistant prostate cancer refractory to docetaxel. Grade 3 to 4 (G3–4) neutropenia and febrile neutropenia were relatively frequent in the registrative XRP6258 Plus Prednisone Compared to Mitoxantrone Pl...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Medicine (Baltimore)
Main Authors: Di Lorenzo, Giuseppe, Bracarda, Sergio, Gasparro, Donatello, Gernone, Angela, Messina, Caterina, Zagonel, Vittorina, Puglia, Livio, Bosso, Davide, Dondi, Davide, Sonpavde, Guru, Lucarelli, Giuseppe, De Placido, Sabino, Buonerba, Carlo
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2016
Teme:
7300
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4718232/
https://ncbi.nlm.nih.gov/pubmed/26765406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002299
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki